7-Hydroxymitragynine

From WikiMD's WELLNESSPEDIA

An alkaloid found in the kratom plant

Chemical Compound
Identifiers
CAS Number
PubChem CID
ChemSpider ID
UNII
ChEBI
ChEMBL
Properties
Chemical Formula
Molar Mass
Appearance
Density
Melting Point
Boiling Point
Hazards
GHS Pictograms [[File:|50px]]
GHS Signal Word
GHS Hazard Statements
NFPA 704 [[File:|50px]]
References

7-Hydroxymitragynine is a naturally occurring indole alkaloid found in the kratom plant, Mitragyna speciosa. It is one of the many active compounds in kratom and is known for its potent opioid effects.

Chemical Structure[edit]

7-Hydroxymitragynine is a derivative of mitragynine, the primary active alkaloid in kratom. It has a similar structure to mitragynine but with a hydroxyl group at the 7-position, which significantly enhances its affinity for opioid receptors.

Pharmacology[edit]

7-Hydroxymitragynine acts as a partial agonist at the mu-opioid receptor, which is responsible for its analgesic and euphoric effects. It is considered to be more potent than mitragynine and has been shown to have a higher binding affinity to opioid receptors.

Effects[edit]

The effects of 7-Hydroxymitragynine include pain relief, sedation, and euphoria. It is also associated with the potential for tolerance and dependence, similar to other opioids.

Metabolism[edit]

7-Hydroxymitragynine is metabolized in the liver, primarily through the action of cytochrome P450 enzymes. Its metabolites are excreted in the urine.

Legal Status[edit]

The legal status of 7-Hydroxymitragynine varies by country. In some regions, it is regulated due to its opioid-like effects, while in others, it remains legal as part of kratom products.

Research[edit]

Research on 7-Hydroxymitragynine is ongoing, with studies focusing on its potential therapeutic uses and its role in the pharmacology of kratom. It is of interest for its analgesic properties and its potential as an alternative to traditional opioids.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.